We observed that while LLC1 reduces the viability of tumor organoids over 72 h of treatment (Fig. 2A and B), normal mammary gland organoids tend to be resistant to LLC1 treatment (Fig. 2C and D). The gene discussed is CIMIP1; the disease is neoplasm.